Clinical Trials in Austin

Showing 6261-6280 of 15,205 trials

Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants

NCT04526210

This is a Phase 1, randomized, 2-period, 2-sequence, cross-over study designed to determine the effect of ALXN1840 on the metabolism of bupropion, a sensitive cytochrome P450 2B6 (CYP2B6) substrate, in healthy male and female participants. The safety and tolerability of ALXN1840 will be determined along with ALXN1840 pharmacokinetics (PK) in plasma as measured via total molybdenum with the coadministration of bupropion.

Wilson Disease

Alexion Pharmaceuticals, Inc.54 participantsStarted Oct 2020

Austin, Texas, United States

COMPLETEDPhase 3< 1 mile

DE-117 Spectrum 5 Study

NCT03697811

Santen will evaluate the intraocular pressure (IOP) lowering effect and efficacy of DE-117 ophthalmic solution 0.002% in latanoprost low/non-responder subjects diagnosed with POAG or OHT

Primary Open-angle Glaucoma and Ocular Hypertension

Santen Inc.107 participantsStarted Sep 2018

Chandler, Arizona, United States • Glendale, California, United States • Mission Hills, California, United States +29 more locations

Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants

DE-117 Spectrum 5 Study

Find Trials by Condition in Austin

Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants

Improving Therapeutic Learning for PTSD

Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease

A Study of TRS01 in Subjects With Active Non-infectious Anterior Uveitis Including Subjects With Uveitic Glaucoma

Maximizing Outcomes in Treating Acute Migraine

Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment

Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses

Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management

Phase II Study to Assess Safety and Efficacy of SL-1002 for Osteoarthritic Knee Pain

Phase 2 Clinical Trial of CartiLife® in the United States

Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

High Dose IL 2 and Entinostat in RCC

KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3)

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial